APA (7th ed.) Citation

Kelly, R. P., Garhyan, P., Raddad, E., Fu, H., Lim, C. N., Prince, M. J., . . . Deeg, M. A. (2015). Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. Diabetes, obesity & metabolism, 17(4), 414-422. https://doi.org/10.1111/dom.12446

Chicago Style (17th ed.) Citation

Kelly, R. P., P. Garhyan, E. Raddad, H. Fu, C. N. Lim, M. J. Prince, J. A. Pinaire, M. T. Loh, and M. A. Deeg. "Short-term Administration of the Glucagon Receptor Antagonist LY2409021 Lowers Blood Glucose in Healthy People and in Those with Type 2 Diabetes." Diabetes, Obesity & Metabolism 17, no. 4 (2015): 414-422. https://doi.org/10.1111/dom.12446.

MLA (9th ed.) Citation

Kelly, R. P., et al. "Short-term Administration of the Glucagon Receptor Antagonist LY2409021 Lowers Blood Glucose in Healthy People and in Those with Type 2 Diabetes." Diabetes, Obesity & Metabolism, vol. 17, no. 4, 2015, pp. 414-422, https://doi.org/10.1111/dom.12446.